ClinicalTrials.Veeva

Menu

Negative Pressure Wound Therapy in the Management of Diabetic Foot Ulcers

A

Assiut University

Status

Unknown

Conditions

Diabetic Foot Ulcer

Treatments

Device: Negative Pressure Wound Therapy

Study type

Observational

Funder types

Other

Identifiers

NCT04093635
VAC in DFUs

Details and patient eligibility

About

Role of Negative Pressure Wound Therapy in the Management of Diabetic Foot Ulcers

• The aim of this study will be to assess negative pressure wound therapy in treating diabetic foot ulcers.

Full description

Diabetic Foot ulcers are a major cause of admission in diabetic patients, and comprise a disproportionately high number of hospital days because of multiple surgical procedures and prolonged length of stay in Hospital.

The improvement in diabetes therapy and the reinforcement of guidelines have reduced the amputation rate. The approach to diabetic foot ulcers has allowed the availability of several medical options to ensure the best local condition and wound healing.

Negative-pressure wound therapy is a non-invasive therapy system that employs a controlled negative pressure using a vacuum device to promote wound healing by removing fluid from open wounds through a sealed dressing or a foam dressing connected to a container.

An earlier study has shown that NPWT reduced the need for subsequent amputations in a 6-month follow-up period. This reflects the importance of this device in management of DFUs and prevents its complications.

As most of the diabetic wounds present with infection, the success of NPWT is still highly dependent upon the adequacy of surgical debridement and antimicrobial coverage.

NPWT provides a moist wound environment ideal for re-epithelialization, growth factor action, angiogenesis, and granulation promotion.

Edema reduction produced by NPWT decreases interstitial pressure and positively promoting wound vessel formation and improving wound circulation and lymphatic drainage, increasing the availability of nutrients, oxygen and antibiotic therapy in the wound area. Some studies showed that NPWT promotes an improvement of balance between proteases and their inhibitors and influences cytokine modulation and promotes a positive wound environment.

Accurate classification of diabetic foot ulcers according to Wagner's classification of ulcers is essential for inter-clinician communication, assessment of healing tendency during management by NPWT.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Acute and chronic diabetic wounds, pressure ulcers.
  • Wagener's Grade I superficial diabetic ulcer.
  • Wagener's Grade II after surgical debridement and an appropriate antibiotic therapy.
  • Ischemic wounds after revascularization.

Exclusion criteria

    • Wagener's Grade III, osteomyelitis and Charcot's joint septic arthritis.
  • Wagener's Grade IV, localized gangrene e.g. toe ,heel.
  • Wagener's Grade V, extensive gangrene involving the whole foot.
  • Septicemia. .
  • Gas forming organism.
  • Wounds resulting from venous insufficiency.
  • Peripheral vascular disease (absent distal pulse).
  • Patients being treated with corticosteroids, immunosuppressive drugs or chemotherapy
  • Any other serious pre-existing cardiovascular, pulmonary and immunological disease.

Trial design

40 participants in 2 patient groups

Group I
Description:
Those patients that will be treated by NPWT.
Treatment:
Device: Negative Pressure Wound Therapy
Group II
Description:
Those patients will be treated with standard saline moist wound care and dressing.
Treatment:
Device: Negative Pressure Wound Therapy

Trial contacts and locations

0

Loading...

Central trial contact

Mustafa Saad; Abdelrahman Ibrahim

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems